These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4842377)

  • 21. Sleep disturbance and serum CPK activity in acute psychosis.
    Meltzer HY; Kupfer DJ; Wyatt R; Snyder F
    Arch Gen Psychiatry; 1970 May; 22(5):398-405. PubMed ID: 4314305
    [No Abstract]   [Full Text] [Related]  

  • 22. [Behavior of serum CPK (creatine phosphokinase) and aldolase levels in psychiatric patients].
    Tropeano G; Del Vecchio M; Amati A; Cocorullo M; Kemali D
    Acta Neurol (Napoli); 1972; 27(4):386-94. PubMed ID: 5085163
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple neuromuscular abnormalities in a paranoid schizophrenic.
    Ross-Stanton J; Schlessinger S; Meltzer HY
    Psychiatry Res; 1980 Sep; 3(1):53-67. PubMed ID: 6934557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum creatine phosphokinase in schizophrenia.
    Meltzer HY
    Am J Psychiatry; 1976 Feb; 133(2):192-7. PubMed ID: 1251926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum prolactin levels in newly admitted psychiatric patients.
    Meltzer HY; Sachar EJ; Frantz AG
    Adv Biochem Psychopharmacol; 1974; 12(0):299-315. PubMed ID: 4422003
    [No Abstract]   [Full Text] [Related]  

  • 26. Physiologic abnormalities of the neuromuscular system in schizophrenia.
    Goode DJ; Meltzer HY; Crayton JW; Mazura TA
    Schizophr Bull; 1977; 3(1):121-38. PubMed ID: 867003
    [No Abstract]   [Full Text] [Related]  

  • 27. [Serum creatine kinase activity in psychoses].
    Linke E; Stracke E; Pannenborg H
    Psychiatr Neurol Med Psychol (Leipz); 1979 Jan; 31(1):11-9. PubMed ID: 441205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
    Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
    Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence pattern of serum creatine phosphokinase levels in repeated acute psychosis.
    Manor I; Hermesh H; Valevski A; Benjamin Y; Munitz H; Weizman A
    Biol Psychiatry; 1998 Feb; 43(4):288-92. PubMed ID: 9513739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study.
    Strasser HC; Lilyestrom J; Ashby ER; Honeycutt NA; Schretlen DJ; Pulver AE; Hopkins RO; Depaulo JR; Potash JB; Schweizer B; Yates KO; Kurian E; Barta PE; Pearlson GD
    Biol Psychiatry; 2005 Mar; 57(6):633-9. PubMed ID: 15780850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creatine phosphokinase activity in newly admitted psychiatric patients.
    Gosling R; Kerry RJ; Orme JE; Owen G
    Br J Psychiatry; 1972 Oct; 121(563):351-5. PubMed ID: 5077090
    [No Abstract]   [Full Text] [Related]  

  • 32. Mean serum creatine kinase activity in patients with functional psychoses.
    Meltzer HY; Ross-Stanton J; Schlessinger S
    Arch Gen Psychiatry; 1980 Jun; 37(6):650-5. PubMed ID: 7387337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Senile plaques and Alzheimer changes of the neurofibrils in psychotic patients, decreased in old age].
    Dusheĭko SD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(7):1029-33. PubMed ID: 5077757
    [No Abstract]   [Full Text] [Related]  

  • 34. Psychomotor activity and serum creatine phosphokinase activity.
    Foster FG; Kupfer DJ
    Arch Gen Psychiatry; 1973 Dec; 29(6):752-8. PubMed ID: 4751815
    [No Abstract]   [Full Text] [Related]  

  • 35. [The significance of changed monoamine oxidases in patients with psychiatric diseases].
    Demisch L
    Nervenarzt; 1982 Aug; 53(8):455-60. PubMed ID: 7133246
    [No Abstract]   [Full Text] [Related]  

  • 36. Hyperprolinemia is a risk factor for schizoaffective disorder.
    Jacquet H; Demily C; Houy E; Hecketsweiler B; Bou J; Raux G; Lerond J; Allio G; Haouzir S; Tillaux A; Bellegou C; Fouldrin G; Delamillieure P; Ménard JF; Dollfus S; D'Amato T; Petit M; Thibaut F; Frébourg T; Campion D
    Mol Psychiatry; 2005 May; 10(5):479-85. PubMed ID: 15494707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association analysis of exon III and exon I polymorphisms of the dopamine D4 receptor locus in Mexican psychotic patients.
    Aguirre AJ; Apiquián R; Fresán A; Cruz-Fuentes C
    Psychiatry Res; 2007 Dec; 153(3):209-15. PubMed ID: 17822780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle enzyme release in the acute psychoses.
    Meltzer H
    Arch Gen Psychiatry; 1969 Jul; 21(1):102-12. PubMed ID: 5793673
    [No Abstract]   [Full Text] [Related]  

  • 40. Malic enzyme 2 and susceptibility to psychosis and mania.
    Lee BD; Walss-Bass C; Thompson PM; Dassori A; Montero PA; Medina R; Contreras S; Armas R; Ramirez M; Pereira M; Salazar R; Leach RJ; Quezada P; Raventos H; Escamilla MA
    Psychiatry Res; 2007 Feb; 150(1):1-11. PubMed ID: 17258816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.